INTRODUCTION
The avermectins (AVMs) are a family of macrocyclic lactones isolated as natural fermentation products from the bacterium Streptomyces avermitilis and characterized by their potent anthelminthic and insecticidal properties [1] [2] [3] [4] [5] . Ivermectin (IVM; 22,23- dihydroAVM Bla), a semi-synthetic AVM analogue, has been widely accepted as the drug of choice for treating a broad spectrum of parasites that affect man and animals [6] [7] [8] . It is marketed as a prophylactic treatment for heartworm disease in dogs and as an endectocide for the treatment of parasitic infections of livestock. It is safe for use in humans and has proved more effective than diethylcarbamazine and the benzimidazoles in the treatment and prevention of human onchocerciasis in Third-World nations. The hallmark of this class of compounds is superior potency and breadth of spectrum against a variety of nematode and insect parasites combined with a lack of toxic side effects against host organisms.
We have used the free-living nematode Caenorhabditis elegans and the fruitfly Drosophila melanogaster as model systems for study of the nematode and insect AVM receptors. High-affinity AVM-binding sites identified in membranes from C. elegans have been shown to be associated with the physiologically relevant drug target in nematodes [9] . AVMs are capable of modulating y-aminobutyric acid (GABA)-gated chloride channels in vertebrate neurons [10] [11] [12] [13] . However, they do not appear to exert their anthelminthic and insecticidal effects through invertebrate GABA receptors [14, 15] . Electrophysiological data generated by injecting C. elegans mRNA into Xenopus oocytes has indicated that the AVMs act at glutamate-gated chloride channels in nematodes [16, 17] .
In a previous publication, the high-affinity drug-binding sites from both C. elegans and D. melanogaster were identified by photoaffinity labelling with a radioactive azido-AVM analogue [18] . The present paper describes the purification of the affinitylabelled AVM-binding proteins by immunoprecipitation using a monoclonal antibody (mAb) specific for the ligand, AVM. using a monoclonal antibody to avermectin covalently attached to Protein A-Sepharose beads. Three affinity-labelled Drosophila proteins with molecular masses between 45 and 50 kDa were isolated in this way and then separated from each other by electroelution. This three-step protocol provides a rapid technique for receptor purification which may be of use in the purification of other binding proteins.
MATERIALS AND METHODS Chemicals
Azido-AVM was supplied by Peter Meinke and Helmut Mrozik (Merck Research Laboratories). The synthesis [19] and iodination ofthe compound [18] Generation of mAb 3A6-1 (anti-AVM antibody) BALB/c mice were immunized by intraperitoneal injections of an AVM-BSA conjugate. At 3 days after the final antigen injection, spleen cells were isolated and fused with the mouse myeloma cell line Sp 2/0 using standard procedures [20] . Hybridoma 3A6 was subcloned once by limiting dilution. The isotype of mAb 3A6-1 is IgGI, as determined by e.l.i.s.a., and the antibody reacts specifically with AVMs (E. B. Jacobson, unpublished work).
Photoaffinity labelling of AVM-binding proteins from C. elegans Photoaffinity labelling of both the C. elegans and the Drosophila tissue preparations have been previously described [18] . The C. elegans receptor was solublized from membranes before affinity labelling. The membrane protein was diluted to 200 ,tg/ml and stirred on ice for 1 h with 0.5 % Triton X-100. Detergent-soluble material was separated from the insoluble fraction by centrifugation at 100000 g. The soluble protein mixture was incubated in the dark at room temperature for 1 h in the presence of 1 Drosophila melanogaster heads were collected by storing whole adult flies at -70 'C in 50 ml polystyrene culture tubes for at least 1 h then shaking vigorously to break apart heads and bodies and sieving to separate bodies from heads. Heads were homogenized with a motor-driven Potter-Elvehjem tissue grinder in 50 mM Hepes, pH 7.4, containing phenylmethanesulphonyl fluoride (0.2 mM), EDTA (1 mM), pepstatin (0.7 mg/l) and leupeptin (0.5 mg/l). The homogenate was centrifuged at 1000 g for 5 min and the pellet discarded. A 28000 g membrane fraction For large-scale purification of the affinity-labelled Drosophila AVM-binding protein, the 125I-azido-AVM was diluted with unlabelled azido-AVM to a final specific radioactivity of 5 Ci/mmol. Cross-linking was performed in 100 ml batches in a large Pyrex tray seated in a second tray of ice/water. The nested trays were placed on a rotary shaker and exposed to u.v. light for 5 min. After cross-linking, the membrane suspension was then centrifuged at 28000 g and the supernatant discarded. Membranes were resuspended in a total volume of 300 ml of Tris/SDS/DTT buffer and left at room temperature for 1 h. The sample was boiled, allowed to cool to room temperature, centrifuged to remove particulates and concentrated to 100 ml in an Amicon ultrafiltration apparatus using a PM 30 membrane.
F.p.l.c. gel-filtration chromatography of the photoaffinity-labelled proteins The photolabelled C. elegans or Drosophila samples were treated for 15 min in a bath sonicator, boiled for 5 min, and then centrifuged in an Eppendorf microfuge for 10 min. The supernatant was partially purified by chromatography on a High Load 16/60 Sephacryl S-300 high-resolution gel-filtration column (Pharmacia) in the presence of 0.1 % SDS, 0.2 M NaCl, 10 mM DTT and 50 mM Tris, pH 7.4. Column fractions were monitored for radioactivity by counting aliquots of each fraction in a yradiation counter. The fractions which contained the major peak of protein-associated radioactivity (the 53 and 47 kDa affinitylabelled proteins from C. elegans or the 45 kDa protein from Drosophila) were pooled and dialysed extensively against 50 mM Tris (pH 8)/300 mM NaCl/0.5 % Triton X-100/5 mM EDTA in order to remove SDS and DTT from the protein sample.
For large-scale Drosophila preparations, a Sephacryl S-300 column (5 cm x 100 cm) with a bed volume of 1800 ml was run at a flow rate of 5 ml/min using a peristaltic pump. The sample volume applied to this column was 50-100 ml. DTT eliminated from the elution buffer for this procedure.
was Coupling mAb 3A6-1 to CNBr-Sepharose beads The AVM-specific mAb 3A6-I was purified from mouse ascites fluid by (NH4)2SO4 precipitation and Protein A-Sepharose chromatography. After precipitation with 500% (NH4)2SO4, 800 mg of protein was resuspended in 50 ml of PBS and dialysed against 5 litres of 0.1 M sodium phosphate buffer at pH 8.6. The sample was loaded on to a 50 ml Protein A-Sepharose column which had been equilibrated with 0.1 M sodium phosphate buffer, pH 8.6. The purified IgGI was eluted from the column with 0.1 M citrate buffer, pH 6.0. Purified antibody was coupled to CNBr-Sepharose according to manufacturer's (Pharmacia) specifications.
Coupling mAb 3A6-1 to Protein A-Sepharose beads Protein A-Sepharose beads (Sigma) were hydrated and washed three times in 10 vol. of 0.2 M sodium borate, pH 9.0, followed by three washes in 10 vol. of 3 M NaCl/0.05 M sodium borate, pH 9.0. All washes, as well as the reactions, were carried out by suspending the beads in the appropriate solution, pelleting the beads at 200 g and then aspirating the supernatant. MAb 3A6-1, partially purified by (NH4)2S04 precipitation of murine ascites fluid, was adjusted to 3 M NaCl/0.05 M sodium borate, pH 9.0, in a volume equal to ten times that of the Protein A beads and with an IgG level of 2 mg/ml of beads. The mixture was maintained at room temperature for 1 h with gentle agitation. The beads were then washed three times with 10 vol. of 3 M NaCl/0.05 M sodium borate, pH 9.0, and then resuspended in 9 vol. of the same buffer. Dimethyl pimelimidate (final concn. 0.2 M) was added to 1 vol. of 3 M NaCl/0.05 M sodium borate in a separate container and adjusted to pH 9.0 with 5 M NaOH. This solution was added immediately to the bead suspension. The beads were mixed gently at room temperature for 20 min, then pelleted and the supernatant removed. The beads were again resuspended in 9 vol. of buffer; fresh dimethyl pimelimidate was prepared, added to the beads, and the slurry incubated for 20 min. After pelleting, the beads were washed in 10 Immunoprecipitaflon of AVM-binding proteins MAb 3A6-1-Sepharose beads were washed with 50 mM Tris, pH 8, containing 300 mM NaCl, 0.5 % Triton X-100 and 5 mM EDTA. The C. elegans or Drosophila proteins eluted from the Sephacryl S-300 gel-filtration column were dialysed against the same buffer. Aliquots of mAb 3A6-1-Sepharose beads (100 #I)
were incubated with 1 ml aliquots of the size-fractionated proteins from either Drosophila (20 
RESULTS
Gel-flltration chromatography Photoaffinity-labelled proteins from C. elegans and from Drosophila were partially purified on a Sephacryl S-300 f.p.l.c. gel-filtration column. Figure 1 shows the elution profile obtained with the photoaffinity-labelled C. elegans protein mixture. Fractions 31-36 contained the radiolabelled 53 and 47 kDa proteins and were pooled and dialysed separately from fractions 45 and 46, which contained the 8 kDa radiolabelled peptide. True size fractionation of proteins as a result of denaturing the sample by boiling in SDS and DTT before application to the S-300 column is shown by SDS/PAGE gel analysis of fractions in the lower panel of Figure 1 . Fractionation of Drosophila proteins by elution from the Sephacryl S-300 column is shown in Figure 2 . Fractions 32-35, which contained the radiolabelled 45 kDa protein, were pooled and dialysed. A 5-10-fold purification of the affinity-labelled proteins was routinely achieved on this column, and all radioactivity could be accounted for at the end of each run. Since the sample was boiled and chromatographed under denaturing conditions, this step also provided a means for unfolding the elegans proteins on Sephacryl S-300 A 2 ml sample of the affinity-labelled C. elegans mixture was loaded on to a Pharmacia HiLoad 16/60 Sephacryl S-300 column at a flow rate of 1 ml/min; 2 ml fractions were collected from the time of sample injection. The peak of radioactivity between fractions 31 and 36, indicated by hatched area, contained the radiolabelled 53 kDa and 47 kDa proteins. The An 1800 ml Sephacryl S-300 column (5 cm x 100 cm) was used for purification of the large-scale Drosophila preparations. This step resulted in a 7-fold purification of the AVM-binding protein ( Table 1) .
immunoprecipitation of AVM-binding proteins Aliquots (200 jig/ml) of the C. elegans S-300 fractions containing the 53 kDa and 47 kDa photoaffinity-labelled proteins were incubated with 100 ,u1 aliquots of either the 3A6-1-or murine IgGl-Sepharose beads (Figure 3) . After a 2 h incubation, the samples were centrifuged and the supernatants (lanes 2 and 3) were analysed separately from the material that bound to the mAb 3A6-1-or the IgGl-Sepharose beads (lanes 4 and 5 respectively). Lane Figure 4 shows the immunoprecipitation of photoaffinity labelled Drosophila AVM-binding proteins by mAb 3A6-1 coupled to either CNBr-Sepharose or to Protein A-Sepharose.
Aliquots of 100 ,ul of the 3A6-I-Sepharose beads were incubated with affinity-labelled Drosophila proteins. In this experiment it was apparent that coupling of the 3A6-1 antibody to Protein A-Sepharose rather than to CNBr-Sepharose yielded a resin with greater antigen-binding capacity. Lanes 1 and 2 contain the supernatant and immunoprecipitate (respectively) from the incubation of 25 ,ug/ml of the Drosophila protein mixture with 100 ,ul of mAb 3A6-1 coupled to CNBr-Sepharose beads. Lanes 3 and 4 contain the supernatant and immunoprecipitate from the incubation of 25 ,ug/ml Drosophila protein mixture with 100 ml of mAb 3A6-1 coupled to Protein A-Sepharose. Lanes 5 and 6 contain the supernatant and immunoprecipitate from the incubation of 50 ,ug/ml Drosophila protein mixture with 100 4ul of mAb 3A6-1 coupled to Protein A-Sepharose. Lanes 7 and 8 contain the supernatant and immunoprecipitate from the incubation of 100 ,tg/ml Drosophila protein mixture with 100 ,ul of mAb 3A6-1 coupled to Protein A-Sepharose. The silverstained panel in Figure 4 demonstrates that, with either the CNBr-Sepharose or the Protein A-coupled resin, non-specific binding of unlabelled Drosophila proteins is negligible. Figure 5 shows the general scheme used for purification of photaffinitylabelled AMV-binding proteins from both C. elegans and D. melanogaster. Denaturation of the labelled protein was essential for efficient subsequent binding to the immuno-affinity column.
The result of a large-scale purification of the affinity-labelled Drosophila AVM-binding protein is shown in Table 1 Aliquots (100 1u) of mAb 3A6-1 coupled either to CNBr-Sepharose or to Protein A-Sepharose were compared in this experiment. Lanes 1 and 2 correspond to the supernatant and immunoprecipitate (respectively) resulting from the incubation of 100 ,l of mAb 3A6-1 coupled to CNBr-Sepharose with a 1 ml aliquot of affinity-labelled Drosophila proteins (25 ,ug/ml). Lanes 3 and 4 correspond to the supernatant and immunoprecipitate (respectively) from the incubation of 100 ,ul of mAb 3A6-1 coupled to Protein A-Sepharose with a 1 ml aliquot of affinity-labelled Drosophila proteins (25 ,ug/ml). Lanes 5 and 6 contain supernatant and immunoprecipitate (respectively) from the incubation of 100 ,zl of mAb 3A6-1 coupled to Protein A-Sepharose with a 1 ml aliquot of affinity-labelled Drosophila proteins (50,ug/ml). Lanes 7 and 8 contain supernatant and immunoprecipitate (respectively) from the incubation of 100 ,ul of mAb 3A6-1 coupled to Protein A-Sepharose with a 1 ml aliquot of affinity-labelled Drosophila proteins (100 ug/ml). Samples were analysed on a SDS/10%-PAGE gel, both by autoradiography and by silver staining. Supernatant samples were precipitated with 80% methanol before loading on to the SDS/PAGE gel. M is molecular mass.
The immunoaffinity-purified material was concentrated by Amicon ultrafiltration and freeze-drying and analysed on SDS/10%-polyacrylamide gels (Figure 6a below) . The major contaminant at 31 kDa was sequenced and found to show considerable sequence similarity to the mouse immunoglobulin light chain. The 50 kDa contaminant is presumed to be the mouse immunoglobulin heavy chain. The three affinity-labelled Drosophila proteins designated by dots in Figure 6 (a) were excised from the gel and electroeluted as shown in Figure 6 (b). Coomassie Blue staining of protein shown in Figure 6 (b) was used to estimate the amount of purified protein obtained (Table 1) . In order to preserve as much protein as possible for subsequent sequencing, exact determination of the pure protein concentration was not performed.
DISCUSSION
AVMs are highly selective for invertebrate tissues, and while they are known to cause an increase in membrane permeability to chloride ions, the precise mechanism by which they exert their paralytic effects in insects and nematodes has yet to be elucidated. In contrast with vertebrate brain, where AVMs interact with GABA-gated chloride channels, they appear to act at a novel glutamate-gated chloride channel in nematodes and insects. The existence of such channels in insects has been well documented [22] [23] [24] [25] [26] , and the likelihood of AVM involvement at such a channel in nematodes, insects and crustaceans has been established [14, 17, 27, 28] . Photoaffinity labelling of AVM-binding sites from C. elegans and D. melanogaster resulted in identification of a limited number of proteins associated with the drug-binding site [18] . Another possibility is that the C. elegans mixture contains tissuespecific forms of the AVM receptor, since the source of tissue was a particulate fraction prepared from whole nematode-worm homogenates, in contrast with the Drosophila tissue, which was prepared from heads only. Our strategy for purification, sequencing and cloning of these proteins was based on a desire to isolate and sequence all affinity-labelled peptides simultaneously. The approach described here involves the use of gel-filtration chromatography under denaturing conditions followed by immunoprecipitation or immunoaffinity chromatography with an antibody specific for the covalently cross-linked AVM ligand. We have demonstrated the ability to isolate and purify all the C. elegans and Drosophila AVM-binding proteins to which the azido-AVM was covalently cross-linked. Unfolding of the labelled proteins by subjecting them to denaturing conditions during gel filtration was a prerequisite for successful immunoprecipitation or immunoaffinity purification of the AVM-binding proteins ( Figure 5) .
To facilitate the large-scale isolation of the Drosophila AVMbinding proteins, mAb 3A6-1 was coupled to Protein A- Sepharose rather than CNBr-Sepharose. In contrast with the random orientation of antibody on the CNBr-Sepharose, all antibody should have been attached and subsequently coupled to Protein A-Sepharose via the Fc portion of the immunoglobulin molecule, thus leaving the antigen-binding site accessible to AVM. The aim was to synthesize a resin with more accessible antigen-binding sites per unit volume of Sepharose beads and, as shown in Figure 4 , the mAb 3A6-1-Protein A-Sepharose beads were able to bind more of the affinity-labelled Drosophila proteins. This approach offered two advantages over conventional chromatography on an AVM-affinity column. Binding of the C. elegans receptor to AVM is nearly irreversible, owing to the high affinity of the interaction and the low rate of dissociation. In order to elute the C. elegans binding proteins from an AVM column, it was necessary to use denaturing conditions, which resulted in loss of biological activity, thus making it impossible to prove which of the eluted proteins were the AVM-binding proteins. In the case of Drosophila, the AVM-binding activity was not soluble in any of several non-ionic detergents tested. Therefore affinity chromatography of the biologically active Drosophila protein on an AVM resin was not feasible.
In our experiments with 125I-azido-AVM, the percentage of high-affinity binding sites undergoing covalent modification ranged between 10 and 20%. Although 10-20% cross-linking efficiency is quite respectable for an aryl azide derivative, it represents the major disadvantage of the method, since our approach facilitates only the purification of the fraction of receptor molecules bearing the covalently attached photoprobe. However, the recent development of a new class of affinity probes with cross-linking efficiencies of 50-60% [29] could enhance the overall efficiency of this purification protocol 5-6- fold.
Approx. 78 pmol of the Drosophila AVM-binding protein were purified using this approach. After elution from the mAb 3A6-1 column, two major contaminants were observed upon SDS/PAGE (Figure 6a) . Sequencing of tryptic peptides from the 31 kDa contaminant identified this protein as mouse immunoglobulin light chain present as a result of leaching of mAb 3A6-1 from the affinity column during elution of the Drosophila receptor. The contaminant at 50 kDa is presumably mouse immunoglobulin heavy chain. Purification of the receptor to homogeneity was achieved by excising the two major and one minor affinity-labelled proteins from SDS/PAGE gels and electroeluting them, thus eliminating the contaminant proteins at 50 kDa and 31 kDa. The protein was purified over 9000-fold from head membranes, as indicated in Table 1 . AVM-binding sites are ten times more abundant in head membranes as compared with membranes prepared from Drosophila bodies, therefore the overall purification of the receptor from whole flies is much greater than 9000-fold [21] .
Several groups have recently succeeded at cloning invertebrate GABA-gated chloride channels [30, 31] and cation-selective glutamate receptors [32, 33] by drawing on sequence similarity between invertebrate and vertebrate receptor homologues. Glutamate-gated chloride channels from invertebrate sources have not been purified or cloned, which could be an indication of extreme structural dissimilarity between the glutamate-gated chloride channels and other known ion channels [34] . Recently, three representatives of a glutamate-transporter gene family were cloned by groups who approached the problem either by first purifying the protein [35, 36] or by using an assay for glutamatetransporter function from cDNA clones expressed in Xenopus oocytes [37] . If the invertebrate AVM-sensitive chloride channel is coded for by a member of a gene family unrelated to that coding for the GABA-gated chloride channels and the cationselective glutamate channels, then cloning it will most likely depend on purification and sequencing of the ion-channel protein or screening of cDNA clones expressed in a Xenopus oocyte system as well.
In summary, we have identified and isolated AVM-binding proteins from both C. elegans and D. melanogaster by combining the approaches of photoaffinity labelling with ligand-targeted immunoprecipitation. Relatively few ion channels have been purified to homogeneity and obtained in quantities adequate for amino acid sequencing. The list includes only the nicotinic acetylcholine receptor from electric tissues of electric rays and eels (see [38] for a review), the GABAA receptor from bovine brain [39] [40] [41] , and a skeletal-muscle L-type Ca2+ channel [42] [43] [44] . We 
